LDLR and metabolic dysfunction-associated steatohepatitis: As expected in the NASH model, the serum ALT and AST level, liver fatty degeneration, liver fibrosis and fibrosis-related genes expression were increased in the Ldlr-/- mice with HFD compared with WT mice with CD.